PMN
|
https://www.ihealthcareanalyst.com/global-alzheimers-disease-market/ The...
|
PMN
|
70,000,000 preferred shares converted into 1,166,667 preferred shares to...
|
PMN
|
Yes, the final proof will be in the clinic. Hopefully the Phase 1b data has...
|
PMN
|
If you review the AAIC poster, available at: https://d1io3yog0oux5...
|
PMN
|
This is my opinion and not investment advice (I'm down 60% after...
|
PMN
|
To the many haters who said this day would never come, it's here. To the...
|
PMN
|
more confirmation of PMN hypothesis See slide 6 and 7 of this presentation...
|
PMN
|
Their cash on hand is more than their market cap by double... just crazy...
|
PMN
|
Its Phase 1a- checking safety, pharmicokinetics, and CSF concentration...
|
PMN
|
Here we go! Thanks for sharing. Great news.
|
PMN
|
I have not been able to find any record of a clinical trial, active or ...
|
PMN
|
When people take a drug that interacts with their brain by design, they will...
|
PMN
|
https://d1io3yog0oux5.cloudfront.net/_723c1ce90d796a40ef5000eda2ca63ef...
|
PMN
|
From our July press release, which briefly catapulted the stock...
|
PMN
|
I'd guess $15-20B at the end of Ph2 if the data shows significant...
|
T.ABX
|
Time to buy calls on Barrick? seems like price per ounce dipping along...
|
V.KALO
|
https://kalogoldcorp.com/2023/09/27/kalo-discovers-new-epithermal-gold-and...
|
PMN
|
https://www.precisionvaccinations.com/vaccines/alzheimers-disease-vaccines
|
PMN
|
ABOS indicated their $200M was sufficient to get through Phase 2. A previous...
|
PMN
|
Best info of the month award goes to goldtech for sharing this... https...
|